Laurel, MD, United States of America

Wasim Haider Chowdhury

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2009-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wasim Haider Chowdhury. Retrieved from https://idiyas.com/inventor/wasim-haider-chowdhury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Wasim Haider Chowdhury**

Introduction

Wasim Haider Chowdhury is a noteworthy inventor based in Laurel, Maryland. He has made significant strides in the field of adenoviral research, boasting three patents that showcase his innovative capabilities. His work is primarily conducted at Johns Hopkins University, where he collaborates with esteemed colleagues to develop novel methodologies and compositions.

Latest Patents

Chowdhury's latest patents include groundbreaking technologies aimed at improving adenoviral vector systems. The first patent, titled "Compositions and methods for generating and screening adenoviral libraries," presents DNA libraries, libraries of viral clones, and libraries of infectious viral particles. This invention outlines methodologies for generating and screening these libraries, providing essential tools for further research.

In addition, his second patent, "Adenoviral fiber exchange shuttle system," offers methods and compositions for generating recombinant adenoviral vectors. This patent also features kits designed for the generation of these vectors, further emphasizing the practical applications of his research.

Career Highlights

Throughout his career, Chowdhury has focused on advancing the understanding and application of adenoviral vectors. His innovative work has the potential to pave the way for new treatment methodologies in gene therapy and vaccine development. Collaborating with other experts in the field, he has contributed to numerous research projects that have garnered attention within the scientific community.

Collaborations

Chowdhury has had the opportunity to work alongside notable colleagues such as Ronald Rodriguez and Shawn Lupold. Their combined expertise and dedication have fostered an environment of innovation and collaboration, enabling the development of cutting-edge technologies in adenoviral research.

Conclusion

Wasim Haider Chowdhury's contributions to the field of adenoviral research exemplify the essence of innovation. His patents demonstrate his commitment to pushing the boundaries of science and improving methodologies that can impact diverse areas such as gene therapy and vaccine development. As he continues his work at Johns Hopkins University, his inventions are poised to play a crucial role in the future of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…